The chemical substance with the name "methyl (1S,2S,3R,5S,8R,9R,10R)-10-[(1R,2E,4E)-6-(2-hydroxy-1-methyl-4-oxo-4,5-dihydro-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxohexa-2,4-dien-1-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.0~1,5~]dodecane-2-carboxylate" and CAS number "69774-86-3" is a complex organic compound characterized by its intricate molecular structure, which includes multiple stereocenters and functional groups. This compound features a tricyclic framework, indicative of its potential biological activity, and includes various substituents such as hydroxyl and carbonyl groups, which may contribute to its reactivity and solubility properties. The presence of multiple methyl groups suggests a degree of hydrophobicity, while the carboxylate moiety may enhance its solubility in polar solvents. Given its structural complexity, this compound may exhibit unique pharmacological properties, making it of interest in medicinal chemistry and drug development. Its specific stereochemistry is crucial for its biological interactions, influencing how it binds to biological targets.

BU-2313 A is a new antibiotic complex active against anaerobes.

methyl (1S,2S,3R,5S,8R,9R,10R)-10-[(1R,2E,4E)-6-(2-hydroxy-1-methyl-4-oxo-4,5-dihydro-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxohexa-2,4-dien-1-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.0~1,5~]dodecane-2-carboxylate (non-preferred name)

69774-86-3: The chemical substance with the name "methyl (1S,2S,3R,5S,8R,9R,10R)-10-[(1R,2E,4E)-6-(2-hydroxy-1-methyl-4-oxo-4,5-dihydro-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxohexa-2,4-dien-1-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.0~1,5~]dodecane-2-carboxylate" and CAS number "69774-86-3" is a complex organic compound characterized by its intricate molecular structure, which includes multiple stereocenters and functional groups. This compound features a tricyclic framework, indicative of its potential biological activity, and includes various substituents such as hydroxyl and carbonyl groups, which may contribute to its reactivity and solubility properties. The presence of multiple methyl groups suggests a degree of hydrophobicity, while the carboxylate moiety may enhance its solubility in polar solvents. Given its structural complexity, this compound may exhibit unique pharmacological properties, making it of interest in medicinal chemistry and drug development. Its specific stereochemistry is crucial for its biological interactions, influencing how it binds to biological targets.

BU-2313 A is a new antibiotic complex. It also active against anaerobes.

CAS 69774-86-3

methyl (1S,2S,3R,5S,8R,9R,10R)-10-[(1R,2E,4E)-6-(2-hydroxy-1-methyl-4-oxo-4,5-dihydro-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxohexa-2,4-dien-1-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.0~1,5~]dodecane-2-carboxylate (non-preferred name)

BU-2313 A

Ref: TM-T23830